SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015968
Filing Date
2021-11-15
Accepted
2021-11-15 16:06:20
Documents
106
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20210930x10q.htm   iXBRL 10-Q 4844469
2 EX-31.1 fbio-20210930xex31d1.htm EX-31.1 13874
3 EX-31.2 fbio-20210930xex31d2.htm EX-31.2 14576
4 EX-32.1 fbio-20210930xex32d1.htm EX-32.1 8241
5 EX-32.2 fbio-20210930xex32d2.htm EX-32.2 8197
  Complete submission text file 0001558370-21-015968.txt   18210687

Data Files

Seq Description Document Type Size
6 EX-101.SCH fbio-20210930.xsd EX-101.SCH 114880
7 EX-101.CAL fbio-20210930_cal.xml EX-101.CAL 93248
8 EX-101.DEF fbio-20210930_def.xml EX-101.DEF 524893
9 EX-101.LAB fbio-20210930_lab.xml EX-101.LAB 738927
10 EX-101.PRE fbio-20210930_pre.xml EX-101.PRE 780456
11 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20210930x10q_htm.xml XML 4053515
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 211410391
SIC: 2834 Pharmaceutical Preparations